Compounds > n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine
Page last updated: 2024-09-03

n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine and perphenazine

n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine has been researched along with perphenazine in 1 studies

Compound Research Comparison

Studies
(n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine)		Trials
(n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine)		Recent Studies (post-2010)
(n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine)		Studies
(perphenazine)		Trials
(perphenazine)		Recent Studies (post-2010) (perphenazine)
250121,666243128

Protein Interaction Comparison

ProteinTaxonomyn,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine (IC50)perphenazine (IC50)
ubiquitin-conjugating enzyme E2 NHomo sapiens (human)14.79
Aldehyde oxidase 1Mus musculus (house mouse)6.1
Retinal dehydrogenase 1Homo sapiens (human)0.5242
Angiotensin-converting enzymeOryctolagus cuniculus (rabbit)4.216
D(2) dopamine receptorHomo sapiens (human)0.0003
Pleiotropic ABC efflux transporter of multiple drugsSaccharomyces cerevisiae S288C1.4
Aldehyde oxidaseHomo sapiens (human)0.033
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)4.216
Aldehyde oxidase 1Macaca fascicularis (crab-eating macaque)3.6
Nuclear receptor subfamily 3 group C member 3 Bos taurus (cattle)4.216
Aldehyde oxidase 1 Rattus norvegicus (Norway rat)0.74

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1

Other Studies

1 other study(ies) available for n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine and perphenazine

ArticleYear
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008